| Nov 7 |
Geron: A Post Earnings And Funding Announcement Assessment
|
| Nov 7 |
Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors
|
| Nov 7 |
Geron Corporation (GERN) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
Geron spikes after Q3 beat and $375M funding deal
|
| Nov 7 |
Geron: Q3 Earnings Snapshot
|
| Nov 7 |
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
|
| Nov 7 |
Geron GAAP EPS of -$0.04 beats by $0.05
|
| Nov 7 |
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
|
| Nov 7 |
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
|
